Compare Boston Scientific Corporation (BSX) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Western Union Co — how do they compare? Boston Scientific Corporation trades at $43.06 (market cap $66.37B), while Western Union Co trades at $8.04 (market cap $2.46B). The key difference: Boston Scientific Corporation is far larger — about 27× Western Union Co's market cap, and Western Union Co pays a 11.93% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | WU | |
|---|---|---|
Market Cap | $66.37B | $2.46B |
Sector | Health | Technology |
52-Week High | $108.14 | $10.28 |
52-Week Low | $42.63 | $7.04 |
Enterprise Value | $75.94B | $2.16B |
Dividend Yield | — | 11.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
Western Union (WU) trades at $7.87, up 0.38% with a bullish technical signal. The stock shows attractive valuation with P/E of 5.79 and P/S of 0.63, supported by strong profitability metrics including 47.66% ROE. Recent earnings show mixed performance with Q1 2026 miss but Q3 and Q4 2025 beats. The company maintains strategic partnerships with Total Wireless and digital expansion initiatives, though revenue has declined from $4.5B in 2022 to $4.05B in 2025.
WU presents a value opportunity with deep valuation discounts but faces revenue headwinds and competitive pressures. The 11.5% dividend yield provides income support, though high debt levels and declining net income margins warrant caution. Analyst consensus remains mixed with 58% hold ratings, reflecting balanced risk-reward amid digital transformation efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
